In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Other Income | 0.3 | 4.5 | 32.1 | 15.8 | 31.6 | 5.8 | |
| Revenue Detail — as filed | |||||||
| + Operating Income | 5,851.2 | 6,083.4 | 6,582.7 | 6,610.2 | 6,618.8 | 6,813.7 | |
| + Income from Investments (net) | 625.3 | 942.7 | 898.9 | 909.0 | 796.7 | 857.9 | |
| Expense Detail — as filed | |||||||
| + Employee Remuneration & Welfare | 393.3 | 430.9 | 409.3 | 463.6 | 424.6 | 426.1 | |
| + Commission (net) | 1,026.4 | 940.8 | 1,012.8 | 1,343.1 | 1,187.6 | 1,250.2 | |
| + Commission & Brokerage (net) | 1,026.4 | 940.8 | 1,012.8 | 1,343.1 | 1,187.6 | 1,250.2 | |
| + Provision — Diminution in Investments | 0.0 | 0.0 | 0.0 | 0.0 | 175.1 | 0.0 | |
| + Provision — Doubtful Debts & Write-offs | 0.0 | 0.0 | 0.0 | 0.0 | 3,924.7 | 0.0 | |
| + Non-operating Expense | 7.3 | -14.4 | -4.9 | 11.8 | 65.6 | -13.8 | |
| + Non-operating Provision — Diminution in Investments | -2.5 | -28.5 | -31.8 | 0.0 | 49.0 | -36.0 | |
| + Non-operating Provision — Doubtful Debts | -1.2 | 0.1 | 4.5 | -3.6 | -0.3 | 0.9 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||||
| Profit before Extraordinary Items | 668.2 | 993.7 | 1,077.3 | 869.8 | 718.2 | 535.7 | |
| Profit / (Loss) before Tax — alt tag | 668.2 | 993.7 | 1,077.3 | 869.8 | 718.2 | 535.7 | |
| + Provision for Tax | 158.6 | 246.6 | 257.7 | 211.0 | 171.6 | 132.5 | |
| Profit / (Loss) after Tax | 509.6 | 747.1 | 819.5 | 658.8 | 546.6 | 403.2 | |
| Profit Carried to Balance Sheet | 6,759.1 | 7,158.8 | 7,978.3 | 8,313.7 | 8,860.2 | 8,914.1 | |
| Per Share — as-filed variants | |||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 10.29 | 15.06 | 16.49 | 13.25 | 10.97 | 8.08 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 10.29 | 15.06 | 16.49 | 13.25 | 10.97 | 8.08 | |
| Appropriations & Transfers | |||||||
| + Transfer to Profit & Loss Account | 415.9 | 654.1 | 752.7 | 571.1 | 545.9 | 233.8 | |
| Reserves & Surplus excl. Revaluation Reserve | 13,807.4 | 14,327.2 | 15,263.3 | 15,691.1 | 16,308.4 | 16,460.0 | |
| + Interim Dividend | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
| + Final Dividend | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Insurance — Revenue Account (Policyholders') | |||||||
| Premium Earned | 5,225.6 | 5,136.1 | 5,651.7 | 5,685.3 | 5,790.5 | 5,950.0 | |
| + Gross Premiums Written | 6,903.9 | 8,052.6 | 7,058.9 | 7,433.0 | 8,073.7 | 8,860.3 | |
| + Net Premium Written | 5,481.0 | 5,610.5 | 5,313.0 | 5,963.5 | 6,487.4 | 6,603.7 | |
| + Operating Expenses — Insurance Business | 665.7 | 738.4 | 742.9 | 791.8 | 785.5 | 785.2 | |
| + Non-operating Expenses — Non-insurance | 11.0 | 14.0 | 22.4 | 15.5 | 16.8 | 21.2 | |
| + Claims Paid | 3,510.3 | 2,910.5 | 3,278.2 | 3,427.8 | 3,924.7 | 3,511.6 | |
| + Incurred Claims | 3,743.2 | 3,750.1 | 4,074.4 | 3,904.2 | 4,099.8 | 4,544.5 | |
| + Change in Outstanding Claims | 232.9 | 839.6 | 796.2 | 476.4 | 175.1 | 1,032.9 | |
| Insurance — Shareholders' Account | |||||||
| + Income — Shareholders' Account | 675.5 | 979.3 | 1,072.3 | 881.6 | 783.8 | 521.9 | |
| + Shareholders' Investment Income | 200.3 | 316.7 | 318.8 | 310.4 | 237.6 | 280.3 | |
| + Transfer from Policyholders' Fund | 415.9 | 654.1 | 752.7 | 571.1 | 545.9 | 233.8 | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||||
| Solvency Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Combined Ratio | 1.03 | 1.03 | 1.05 | 1.04 | 1.01 | 1.07 | |
| Incurred Claim Ratio | 0.72 | 0.73 | 0.72 | 0.69 | 0.71 | 0.76 | |
| Net Retention Ratio | 0.79 | 0.70 | 0.75 | 0.80 | 0.80 | 0.75 | |
| Expenses of Management Ratio | 0.33 | 0.28 | 0.32 | 0.35 | 0.32 | 0.29 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Investor Complaints — During the Period | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | -1.00 | |
| Investor Complaints — Received | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | |
| Investor Complaints — Disposed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | |
| Related-party Transactions — During the Period | 1,957.0 | — | 1,946.0 | — | 2,135.9 | — | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Operating Expenses | 5,435.3 | 5,429.2 | 5,830.0 | 6,039.1 | 6,072.9 | 6,579.9 | |
| Other Operating Expenses | 272.3 | 307.5 | 333.6 | 328.2 | 361.0 | 359.1 | |